RETRACTED: Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tumstatin (Tum) is a powerful angiostatin that inhibits proliferation and induces apoptosis of tumorous vascular endothelial cells. A nonpathogenic and anaerobic bacterium, Bifidobacterium longum (BL), selectively localizes to and proliferates in the hypoxia location within solid tumor. The aims of this study were to develop a novel delivery system for Tum using engineered Bifidobacterium and to investigate the inhibitory effect of Tum on tumor in mice. A vector that enabled the expression of Tum under the control of the pBBADs promoter of BL was constructed and transformed into BL NCC2705 by electroporation. The mouse colon carcinoma cells CT26 (1 × 10(7)/mL) were subcutaneously inserted in the left armpit of BALB/c mice. The tumor-bearing mice were treated with Tum-transformed BL, and green fluorescent protein (GFP)-transformed BL was used as a negative control. The microvessel density (MVD) in the transplanted tumor was determined, and terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick end labeling was used to detect apoptosis of vascular endothelial cells in transplanted tumor. The in vitro expression of Tum was examined in BL after l-arabinose induction. Bifidobacterium longum with pBBAD-Tum (BL-Tum) showed significant antitumor effect in tumor-bearing mice. The weight, volume, growth, and MVD, as well as the percentage of apoptotic vascular endothelial cells of transplanted tumors in the tumor-bearing mice treated with Tum-transformed BL were all significantly lower than those in the GFP negative control group. Intragastric administration, injection in tumor and vena caudalis injection of Tum-transformed BL exerted marked antitumor effects in tumor-bearing mice. This is the first demonstration of the utilization of Tum-transformed BL as a specific gene delivery system for treating tumor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a similar study, Wei et al. engineered Bifidobacterium longum to express the proapoptotic compound, tumstatin68. This strain was shown to inhibit tumor growth in a mouse model by various routes of administration68.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [68]
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Uncontrolled angiogenesis plays an important role in tumor growth,(2) and newly formed blood vessels mediate tumor metastasis.(3,4) Uncontrolled angiogenesis is required for tumor growth, which is a result of the imbalance between the amounts of growth factors and growth inhibition factors.”
BackgroundAntiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683 · cited 1×
“Thirty days after bacterial treatments, the mice were killed, the tumors were excised, weighed, and the volumes were calculated (tumor volume 1⁄4 ðwidthÞ(2) length 0:52Þ.(24) The degree of tumor growth inhibition was determined using the formula (weight of tumor in control group weight of tumor in treatment groupÞ=wei…”
MethodMicrobial Dysbiosis in Colorectal Cancer (CRC) Patients
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Van Nhieu, J. T., & Furet, J. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016393 · Cited by 842
Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis
Maeshima, Y., Sudhakar, A., Lively, J. C., Ueki, K., Kharbanda, S., Kahn, C. R., Sonenberg, N., Hynes, R. O., & Kalluri, R. (2002) · Science · doi:10.1126/science.1065298 · Cited by 438
Aflatoxin B1 Binding by Dairy Strains of Lactic Acid Bacteria and Bifidobacteria
Peltonen, K., El-Nezami, H., Haskard, C., Ahokas, J., & Salminen, S. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)74660-7 · Cited by 391
Yazawa, K., Fujimori, M., Amano, J., Kano, Y., & Taniguchi, S. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700122 · Cited by 241
Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 231
Liu, S.-C., Minton, N., Giaccia, A., & Brown, J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301659 · Cited by 194
Yazawa, K., Fujimori, M., Nakamura, T., Sasaki, T., Amano, J., Kano, Y., & Taniguchi, S. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010644217648 · Cited by 161
Hamano, Y., & Kalluri, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.130 · Cited by 134
Altonsy, M. O., Andrews, S. C., & Tuohy, K. M. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.11.015 · Cited by 127
Role of angiogenesis in the pathogenesis of cancer
Hoff, P. M., & Machado, K. K. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.006 · Cited by 118
Orally Administered Bifidobacteria as Vehicles for Delivery of Agents to Systemic Tumors
Cronin, M., Morrissey, D., Rajendran, S., El Mashad, S. M., van Sinderen, D., O'Sullivan, G. C., & Tangney, M. (2010) · Molecular Therapy · doi:10.1038/mt.2010.59 · Cited by 117
Kim, S. W., Kim, H. M., Yang, K. M., Kim, S.-A., Kim, S.-K., An, M. J., Park, J. J., Lee, S. K., Kim, T. I., Kim, W. H., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21262 · Cited by 105
Sekine, K., Ohta, J., ONISHI, M., TATSUKI, T., Shimokawa, Y., Toida, T., KAWASHIMA, T., & Hashimoto, Y. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.148 · Cited by 92
Fu, G., Li, X., Hou, Y., Fan, Y., Liu, W., & Xu, G. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700758 · Cited by 91
Zhu, H., Li, Z., Mao, S., Ma, B., Zhou, S., Deng, L., Liu, T., Cui, D., Zhao, Y., He, J., et al. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.57 · Cited by 90
Matsumoto, M., & Benno, Y. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.016 · Cited by 75
Tang, W., He, Y., Zhou, S., Ma, Y., & Liu, G. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-155 · Cited by 75
Yf, X., Zhu, L.-P., Hu, B., Fu, G.-F., Zhang, H.-Y., Wang, J.-J., & Xu, G.-X. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701003 · Cited by 73
Self-citationYi, C., Huang, Y., Guo, Z.-Y., & Wang, S.-R. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00094.x · Cited by 65
Kawaguchi, T., Yamashita, Y., Kanamori, M., Endersby, R., Bankiewicz, K. S., Baker, S. J., Bergers, G., & Pieper, R. O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1540 · Cited by 58
Oxygenation of malignant tumors after localized microwave hyperthermia
Vaupel, P. W., Otte, J., & Manz, R. (1982) · Radiation and Environmental Biophysics · doi:10.1007/bf01323754 · Cited by 50
Long, R. T., Zeng, W., Chen, L. Y., Guo, J., Lin, Y., Huang, Q., & Luo, S. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.277 · Cited by 50
Self-citationYao, J., Wang, J., Lai, M.-G., Li, Y., Zhu, H., Shi, R., Mo, J., Xun, A.-Y., Jia, C., Feng, J.-L., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100331r · Cited by 40
Self-citationGuglielmetti, S., Ciranna, A., Mora, D., Parini, C., & Karp, M. T. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.03.033 · Cited by 31
Reyes‐Escogido, M. D. L., León‐Rodríguez, A. D., & de la Rosa, A. P. B. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9376-8 · Cited by 31
Li, Z.-J., Zhu, H., Ma, B., Zhao, F., Mao, S.-H., Liu, T.-G., He, J., Deng, L.-C., Cheng, Y., & Huang, Y. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-155 · Cited by 30
Park, M. S., Kwon, B., Shim, J. J., Huh, C. S., & Ji, G. E. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9514-3 · Cited by 29
Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies
Sauer, G., & Deißler, H. (2003) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200302000-00007 · Cited by 27
Yao, B. W., He, Q., Tian, L., Xiao, F., Jiang, Y., Zhang, R., Li, G., Zhang, L., Hou, J., Wang, L., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1075 · Cited by 26
Self-citationThe anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma
Li, Y., Sun, L., He, Y., Liu, X., Liu, M., Wang, Q., & Jin, X. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.111 · Cited by 26
Self-citationChung, I.-S., Son, Y., Ko, Y., Baek, C., Cho, J. K., & Jeong, H. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.01.017 · Cited by 26
Implication of tumstatin in tumor progression of human bronchopulmonary carcinomas
Caudroy, S., Cucherousset, J., Lorenzato, M., Zahm, J., Martinella-Catusse, C., Polette, M., & Birembaut, P. L. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.06.008 · Cited by 21
Yu, Z., Huang, Z., Sao, C., Huang, Y., Zhang, F., Yang, J., Lian, J., Zeng, Z., Luo, W., Zeng, W., et al. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.10.022 · Cited by 17
Self-citationXie, N., Wang, Y., Wang, Q., Li, F., & Guo, B. (2012) · Bulletin du Cancer · doi:10.1684/bdc.2012.1571 · Cited by 16
Cao, J., Peng, S., Sun, L., Li, H., Wang, L., & Deng, H. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00183.x · Cited by 16
Self-citationExpression, purification, and bioactivity of human tumstatin from Escherichia coli
Gu, Q., Zhang, T., Luo, J., & Wang, F. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.01.011 · Cited by 14
Li, W., Zhai, L., Tang, Y.-X., Cai, J., Liu, M., & Zhang, J. (2012) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504012x13473664562466 · Cited by 13
Zhang, G., Zhang, Y., Fu, S., Liu, X., Fu, X., Yan, Y. U., & Zhang, Z. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811020-00020 · Cited by 11
Kawano, A., Ishikawa, H., Nakamura, T., & Kono, K. (2010) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.65.422 · Cited by 9
Cited by
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523
Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy
Górska, A., Przystupski, D., Niemczura, M. J., & Kulbacka, J. (2019) · Current Microbiology · doi:10.1007/s00284-019-01679-8 · Cited by 344
Recent Development of Probiotic Bifidobacteria for Treating Human Diseases
Chen, J., Chen, X., & Ho, C. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.770248 · Cited by 241
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Li, Z., Xiong, W., Liang, Z., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 176
Self-citationSynthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity
Ozdemir, T., Fedorec, A. J. H., Danino, T., & Barnes, C. P. (2018) · Cell Systems · doi:10.1016/j.cels.2018.06.008 · Cited by 159
Metadata
- Authors
- Wei, C., Xun, A. Y., Wei, X. X., Yao, J., Wang, J. Y., Shi, R. Y., Yang, G. H., Li, Y. X., Xu, Z. L., Lai, M. G., Zhang, R., Wang, L.-S., & Zeng, W. S.
- Affiliations
- ShenZhen People’s Hospital (CN)
- Peking University Shenzhen Hospital (CN)
- Henan Medical University (CN)
- Shenzhen Children's Hospital (CN)
- Southern Medical University (CN)
- Corresponding author
- Wang, L.-S.
- Venue
- Technology in Cancer Research & Treatment
- Publisher
- SAGE Publications
- Published
- 2015-05-11
- Volume
- 15
- Issue
- 3
- Pages
- 498-508
- ISSN
- 1533-0338 (ISSN-L)
- 1533-0346
- OpenAlex
- W282488153
- Cited by
- 75
- References
- 41
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 11 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 2
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2026-01-07)
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Technology in Cancer Research & Treatment (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- tumstatin, Bifidobacterium longum, tumor angiogenesis inhibition, colon cancer, tumor microvessel density, intragastric administration, retracted article
- MeSH terms
- Bifidobacterium longum, Animals, Autoantigens, Disease Models, Animal, Genetic Vectors, Humans, Male, Mice, Inbred BALB C, Neoplasms, Experimental, Genetic Therapy, Collagen Type IV, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.